Publications by authors named "Rafael Rosell"

100Publications

Commentary: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.

Front Oncol 2020 10;10:1726. Epub 2020 Sep 10.

Germans Trias i Pujol Research Institute and Hospital, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2020.01726DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511626PMC
September 2020

CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer.

Transl Lung Cancer Res 2020 Aug;9(4):1074-1083

Molecular Oncology Laboratory, Fundación para la Investigación del Hospital General Universitario de Valencia, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr-19-445DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481598PMC
August 2020

Proprotein convertase furin in SARS-CoV-2 and non-small cell lung cancer.

Transl Lung Cancer Res 2020 Aug;9(4):945-947

College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr-20-716DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481648PMC
August 2020

Safety of Anti-PD-L1 Inhibition in HIV-1-Infected Patients With Cancer-Reply.

JAMA Oncol 2020 Sep 10. Epub 2020 Sep 10.

Translational Cancer Research Unit, Instituto Oncológico Dr Rosell, Dexeus University Hospital, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2020.3400DOI Listing
September 2020

Keynote 407: the combination of pembrolizumab and chemotherapy cracks the shell of squamous cell lung cancer.

Transl Lung Cancer Res 2020 Jun;9(3):828-832

Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr-20-400DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354136PMC
June 2020

Mechanisms of resistance to osimertinib.

J Thorac Dis 2020 May;12(5):2851-2858

Medical Oncology Unit, Department of Human Pathology "G. Barresi", University of Messina, Messina, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2019.08.30DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330330PMC
May 2020

Impact of the APE1 Redox Function Inhibitor E3330 in Non-small Cell Lung Cancer Cells Exposed to Cisplatin: Increased Cytotoxicity and Impairment of Cell Migration and Invasion.

Antioxidants (Basel) 2020 Jun 24;9(6). Epub 2020 Jun 24.

Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Professor Gama Pinto, 1649-003 Lisboa, Portugal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/antiox9060550DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346157PMC
June 2020

Targeting MET amplification in EGFR-mutant non-small-cell lung cancer.

Lancet Respir Med 2020 May 29. Epub 2020 May 29.

Medical Oncology Unit, AOU Policlinico G Martino, Department of Human Pathology, University of Messina, Messina, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(20)30171-5DOI Listing
May 2020

Neoadjuvant atezolizumab plus chemotherapy in resectable non-small-cell lung cancer.

Lancet Oncol 2020 06 7;21(6):736-738. Epub 2020 May 7.

Laboratory of Cellular and Molecular Biology, Institute for Health Science Research Germans Trias i Pujol, Badalona 08916, Spain; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(20)30146-7DOI Listing
June 2020

Correction to: The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.

Curr Oncol Rep 2020 May 3;22(5):52. Epub 2020 May 3.

Pangaea Oncology, Laboratory of Molecular Biology, Quirón-Dexeus University Institute, Sabino Arana 5-19, 08028, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-020-00914-xDOI Listing
May 2020

Identification of a novel PAK1 inhibitor to treat pancreatic cancer.

Acta Pharm Sin B 2020 Apr 16;10(4):603-614. Epub 2019 Dec 16.

Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.apsb.2019.11.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161699PMC
April 2020

Lung cancer in never smokers: The role of different risk factors other than tobacco smoking.

Crit Rev Oncol Hematol 2020 Apr 31;148:102895. Epub 2020 Jan 31.

Hospital San Juan de Dios, San José, Costa Rica. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2020.102895DOI Listing
April 2020

Osimertinib and pterostilbene in EGFR-mutation-positive non-small cell lung cancer (NSCLC).

Int J Biol Sci 2019 7;15(12):2607-2614. Epub 2019 Sep 7.

Pangaea Oncology, Laboratory of Molecular Biology, Quirón-Dexeus University Institute, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/ijbs.32889DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854375PMC
July 2020

Targeting PKCι-PAK1 in EGFR-mutation positive non-small cell lung cancer.

Transl Lung Cancer Res 2019 Oct;8(5):667-673

Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2019.08.25DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835115PMC
October 2019

Novel molecular targets for the treatment of lung cancer.

Curr Opin Oncol 2020 01;32(1):37-43

Thoracic Oncology Unit, National Cancer Institute (INCan), Mexico City, Mexico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000590DOI Listing
January 2020

Are neutralising anti-VEGF or VEGFR2 antibodies necessary in the treatment of EGFR-mutated non-small-cell lung cancer?

Lancet Oncol 2019 12 4;20(12):1617-1618. Epub 2019 Oct 4.

Germans Trias i Pujol Research Institute and Hospital, Badalona 08916, Spain; Universitat Autónoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30636-9DOI Listing
December 2019

Lung cavitation in lung metastases of gastric and non-small-cell lung cancer patients treated with apatinib.

Transl Lung Cancer Res 2019 Aug;8(4):317-318

Institute of Oncology Rosell (IOR), Quirón-Dexeus University Institute, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2019.08.20DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749130PMC
August 2019

Characterising acquired resistance to erlotinib in non-small cell lung cancer patients.

Expert Rev Respir Med 2019 10 19;13(10):1019-1028. Epub 2019 Aug 19.

Pangaea Oncology, Laboratory of Molecular Biology, Quiron-Dexeus University Institute , Barcelona , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17476348.2019.1656068DOI Listing
October 2019

Dacomitinib for the first-line treatment of patients with EGFR-mutated metastatic non-small cell lung cancer.

Expert Rev Clin Pharmacol 2019 Sep 5;12(9):831-840. Epub 2019 Aug 5.

Catalan Institute of Oncology, Germans Trias i Pujol University Hospital , Badalona , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17512433.2019.1649136DOI Listing
September 2019

Profile of alectinib for the treatment of ALK-positive non-small cell lung cancer (NSCLC): patient selection and perspectives.

Onco Targets Ther 2019 13;12:4567-4575. Epub 2019 Jun 13.

Molecular and Cellular Oncology Laboratory, Pangaea Oncology, Laboratory of Molecular Biology, Quiron-Dexeus University Institute, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S174548DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580130PMC
June 2019

Effects of dose modifications on the safety and efficacy of dacomitinib for mutation-positive non-small-cell lung cancer.

Future Oncol 2019 Aug 17;15(24):2795-2805. Epub 2019 Jul 17.

Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, PR China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0299DOI Listing
August 2019

Salvage surgery after definitive chemo-radiotherapy for patients with Non-Small Cell Lung Cancer.

Lung Cancer 2019 07 13;133:117-122. Epub 2019 May 13.

Medical Oncology Department, Rosell Oncology Institute (IOR), Dexeus University Hospital, Quironsalud Group, C/ Sabino Arana 5-19, 08028, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.05.010DOI Listing
July 2019

Co-mutations in EGFR driven non-small cell lung cancer.

EBioMedicine 2019 04 20;42:18-19. Epub 2019 Mar 20.

Merck KgaA, Darmstadt, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2019.03.037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491418PMC
April 2019

Cancer Stem Cell Biomarkers in EGFR-Mutation-Positive Non-Small-Cell Lung Cancer.

Clin Lung Cancer 2019 05 21;20(3):167-177. Epub 2019 Feb 21.

Pangaea Oncology, Laboratory of Molecular Biology, Quirón-Dexeus University Institute, Barcelona, Spain; Instituto Oncológico Dr Rosell (IOR), Quirón-Dexeus University Institute, Barcelona, Spain; Institut d'Investigació en Ciències Germans Trias i Pujol, Badalona, Spain; Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2019.02.005DOI Listing
May 2019

Association between the novel classification of lung adenocarcinoma subtypes and EGFR/KRAS mutation status: A systematic literature review and pooled-data analysis.

Eur J Surg Oncol 2019 05 16;45(5):870-876. Epub 2019 Feb 16.

Department of Thoracic Surgery/Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Disease, China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou, PR China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejso.2019.02.006DOI Listing
May 2019

Biological therapies in lung cancer treatment: using our immune system as an ally to defeat the malignancy.

Expert Opin Biol Ther 2019 05 27;19(5):457-467. Epub 2019 Feb 27.

a Cancer Biology and Precision Medicine , Institute for Health Science Research Germans Trias i Pujol (IGTP) , Badalona , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2019.1582635DOI Listing
May 2019

Tumor mutational burden as predictive factor of response to immunotherapy.

Transl Lung Cancer Res 2018 Dec;7(Suppl 4):S358-S361

Dr. Rosell Oncology Institute (IOR), Dexeus University Hospital, Quironsalud Group, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2018.10.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328696PMC
December 2018

Challenges and unanswered questions for the next decade of immune-oncology research in NSCLC.

Transl Lung Cancer Res 2018 Dec;7(6):691-702

Pangaea Oncology, Laboratory of Molecular Biology, Quiron-Dexeus University Institute, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2018.06.08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249614PMC
December 2018

Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC).

EBioMedicine 2019 Jan 22;39:207-214. Epub 2018 Nov 22.

Coyote Research Group, Pangaea Oncology, Laboratory of Molecular Biology, Quiron-Dexeus University Institute, Barcelona, Spain; Institut d'Investigació en Ciències Germans Trias i Pujol, Badalona, Spain; Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523964183054
Publisher Site
http://dx.doi.org/10.1016/j.ebiom.2018.11.036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354556PMC
January 2019

Association of PALB2 Messenger RNA Expression with Platinum-Docetaxel Efficacy in Advanced Non-Small Cell Lung Cancer.

J Thorac Oncol 2019 02 22;14(2):304-310. Epub 2018 Nov 22.

Pangaea Oncology, Laboratory of Molecular Biology, Quiron-Dexeus University Institute, Barcelona, Spain; Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain; Medical Oncology Service, Hospital General de Valencia, Valencia, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.10.168DOI Listing
February 2019

ARID1A Gene Driver Mutations in Lung Adenocarcinomas.

J Thorac Oncol 2018 12;13(12):e255-e257

Catalan Institute of Oncolgy, Hospital Germans Trias i Pujol, Institute for Health Science Research Germans Trias i Pujol, Badalona, Spain; Institute of Oncology Rosell, Quiron-Dexeus University Institute; and Pangaea Oncology, Laboratory of Molecular Biology, Quiron-Dexeus University Institute, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.07.099DOI Listing
December 2018

Strategies for first-line immunotherapy in squamous cell lung cancer: are combinations a game changer?

Transl Lung Cancer Res 2018 Sep;7(Suppl 3):S198-S201

Pangaea Oncology, Laboratory of Molecular Biology, Quiron-Dexeus University Institute, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://tlcr.amegroups.com/article/view/22760/18264
Publisher Site
http://dx.doi.org/10.21037/tlcr.2018.07.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193917PMC
September 2018

Inhibition of MEK, a canonical KRAS pathway effector in mutant NSCLC.

Transl Lung Cancer Res 2018 Sep;7(Suppl 3):S183-S186

Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2018.03.20DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193900PMC
September 2018

Rhomboids and regulation of receptor tyrosine kinase ligands shedding.

EBioMedicine 2018 Nov 6;37:19-20. Epub 2018 Oct 6.

Catalan Institute of Oncology, Germans Trias i Pujol Research Institute and Hospital, Badalona, Barcelona 08028, Spain. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523964183041
Publisher Site
http://dx.doi.org/10.1016/j.ebiom.2018.09.053DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284349PMC
November 2018

Avelumab in non-small-cell lung cancer.

Lancet Oncol 2018 11 24;19(11):1423-1424. Epub 2018 Sep 24.

Dr Rosell Oncology Institute, University Hospital Sagrat Cor, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30683-1DOI Listing
November 2018

Genomic profiling in advanced stage non-small-cell lung cancer patients with platinum-based chemotherapy identifies germline variants with prognostic value in SMYD2.

Cancer Treat Res Commun 2018 1;15:21-31. Epub 2018 Mar 1.

Genomes For life-GCAT Lab. Program of Predictive and Personalized Medicine of Cancer (PMPPC), Institute for Health Science Research Germans Trias i Pujol (IGTP), Can Ruti Biomedical Campus, Crta de Can Ruti, Camí de les Escoles S/N, 08916 Badalona, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2018.02.003DOI Listing
June 2019

Activation of viral defense signaling in cancer.

Ther Adv Med Oncol 2018 29;10:1758835918793105. Epub 2018 Aug 29.

Rosell Oncology Institute (IOR), Dexeus University Hospital, Quironsalud Group, Barcelona, Spain Rosell Oncology Institute (IOR), Sagrat Cor University Hospital, Quironsalud Group, Barcelona, Spain Catalan Institute of Oncology, Germans Trias I Pujol University Hospital, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835918793105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116077PMC
August 2018

Therapeutic approaches for T790M mutation positive non-small-cell lung cancer.

Expert Rev Anticancer Ther 2018 10 14;18(10):1021-1030. Epub 2018 Aug 14.

c Coyote Research Group, Pangaea Oncology, Laboratory of Molecular Biology , Quirón-Dexeus University Institute , Barcelona , Spain.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14737140.2018.1
Publisher Site
http://dx.doi.org/10.1080/14737140.2018.1508347DOI Listing
October 2018

How to optimize the treatment strategy for patients with EGFR-mutant stage IA lung adenocarcinoma: an international multidisciplinary team.

J Thorac Dis 2018 Jun;10(6):3883-3890

Department of Medical Oncology, Shanghai Pulmonary Hospital, Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai 200433, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2018.06.101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051847PMC
June 2018

The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.

Curr Oncol Rep 2018 07 20;20(9):70. Epub 2018 Jul 20.

Pangaea Oncology, Laboratory of Molecular Biology, Quirón-Dexeus University Institute, Sabino Arana 5-19, 08028, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-018-0720-zDOI Listing
July 2018

Circulating tumour DNA genomics in EGFR-mutant lung adenocarcinoma.

Lancet Respir Med 2018 09 17;6(9):649-651. Epub 2018 Jul 17.

Germans Trias i Pujol Research Institute, Barcelona, Spain; Institute of Oncology, University Hospital Sagrat Cor, QuironSalud Group, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(18)30292-3DOI Listing
September 2018

Gene Expression Signatures Predicting Survival and Chemotherapy Benefit in Patients with Resected Non-small-Cell Lung Cancer.

EBioMedicine 2018 07;33:16-17

Medical Oncology Department, University Hospital Sagrat Cor, QuironSalud Group, Institute of Oncology Rosell, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2018.06.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085495PMC
July 2018

Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.

J Clin Oncol 2018 08 4;36(22):2244-2250. Epub 2018 Jun 4.

Tony S. Mok, State Key Laboratory of South China, Chinese University of Hong Kong, Hong Kong; Ying Cheng, Jilin Provincial Cancer Hospital, Changchun; Xiangdong Zhou, First Affiliated Hospital of Third Military Medical University, Chongqing; Yi-Long Wu, Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China; Ki Hyeong Lee, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea; Kazuhiko Nakagawa, Kindai University Hospital, Osaka; Seiji Niho, National Cancer Center Hospital East, Kashiwa, Japan; Min Lee, SFJ Asia Pacific, Singapore; Rolf Linke, SFJ Pharmaceuticals Group, Pleasanton, CA; Rafael Rosell, Catalan Institute of Oncology, Barcelona; Jesus Corral, Hospital Universitario Virgen del Rocio, Seville, Spain; Maria Rita Migliorino, Pulmonary Oncology Unit, San Camillo-Forlanini Hospital, Rome, Italy; Adam Pluzanski, The Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland; Eric I. Sbar, Pfizer, Collegeville, PA; Tao Wang and Jane Liang White, Pfizer, Groton, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.7994DOI Listing
August 2018

Osimertinib in untreated epidermal growth factor receptor ()-mutated advanced non-small cell lung cancer.

Transl Lung Cancer Res 2018 Apr;7(Suppl 2):S165-S170

Medical Oncology Unit, Department of Human Pathology of Adult and Evolutive Age "G. Barresi", University of Messina, Messina, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2018.03.19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943214PMC
April 2018

Liquid biopsy for lung cancer early detection.

J Thorac Dis 2018 Apr;10(Suppl 7):S882-S897

Cancer Biology and Precision Medicine Program, Germans Trias i Pujol University Hospital, Badalona, Spain.

View Article

Download full-text PDF

Source
http://jtd.amegroups.com/article/view/20370/15798
Publisher Site
http://dx.doi.org/10.21037/jtd.2018.03.81DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945693PMC
April 2018

Coordinated strategies for early detection of lung cancer.

Authors:
Rafael Rosell

J Thorac Dis 2018 Apr;10(Suppl 7):S776

Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Badalona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2018.04.10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945697PMC
April 2018

Anti-Epidermal Growth Factor Vaccine Antibodies Enhance the Efficacy of Tyrosine Kinase Inhibitors and Delay the Emergence of Resistance in EGFR Mutant Lung Cancer Cells.

J Thorac Oncol 2018 09 8;13(9):1324-1337. Epub 2018 May 8.

Instituto Oncológico Dr. Rosell (IOR), Quirón-Dexeus University Institute, Barcelona, Spain; Catalan Institute of Oncology and Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.04.030DOI Listing
September 2018

STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer.

Ther Adv Med Oncol 2018 2;10:1758835918763744. Epub 2018 Apr 2.

Coyote Research Group, Pangaea Oncology, Laboratory of Molecular Biology, Quirón-Dexeus University Institute, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835918763744DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888808PMC
April 2018

Clinical assessment of immune-related adverse events.

Ther Adv Med Oncol 2018 30;10:1758835918764628. Epub 2018 Mar 30.

Department of Medical Oncology, Dr Rosell Oncology Institute, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835918764628DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882039PMC
March 2018

Science and biology drives the immune system to cure lung cancer patients: a revolution but not without challenges.

Ther Adv Med Oncol 2018 22;10:1758835918763723. Epub 2018 Mar 22.

Instituto Oncológico Dr Rosell (IOR), Quirón-Dexeus University Institute, Barcelona, Spain; Institut d'Investigació en Ciències Germans Trias i Pujol, Badalona, Spain; Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835918763723DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871042PMC
March 2018

The Value of Early Depth of Response in Predicting Long-Term Outcome in EGFR-Mutant Lung Cancer.

J Thorac Oncol 2018 06 23;13(6):792-800. Epub 2018 Mar 23.

Graduate Institute of Oncology, National Taiwan University and Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.03.010DOI Listing
June 2018

RNA Analysis as a Tool to Determine Clinically Relevant Gene Fusions and Splice Variants.

Arch Pathol Lab Med 2018 Apr;142(4):474-479

From the Department of Pathology, Hospital Clínic, Barcelona, Spain (Dr Teixidó); Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain (Dr Teixidó); Pangaea Oncology, Oncology Laboratory, Dexeus University Hospital - Quirónsalud Group, Barcelona, Spain (Ms Giménez-Capitán and Drs Molina-Vila, Peg, Karachaliou, Castellví, and Rosell); the Department of Pathology, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain (Drs Peg and Castellví); Morphological Sciences Department, Universitat Autònoma de Barcelona, Barcelona, Spain (Drs Peg and Castellví); Institute of Oncology Rosell (IOR), University Hospital Sagrat Cor and Quirónsalud Group, Barcelona, Spain (Drs Karachaliou and Rosell); the Department of Medical Oncology, Canarias University Hospital, San Cristóbal de La Laguna, Tenerife, Spain (Dr Rodríguez-Capote); and Cancer Biology & Precision Medicine Program, Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Badalona, Spain (Dr Rosell).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0134-RADOI Listing
April 2018

An innovative mesothelioma treatment based on miR-16 mimic loaded EGFR targeted minicells (TargomiRs).

Transl Lung Cancer Res 2018 Feb;7(Suppl 1):S1-S4

Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2017.12.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835633PMC
February 2018

Adjuvant therapy for resected EGFR-mutant non-small-cell lung cancer.

Lancet Oncol 2018 03;19(3):e126

University Hospital Sagrat Cor, Quirónsalud Group, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30071-8DOI Listing
March 2018